Bioadaptives (BDPT) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to -$59273.0.
- Bioadaptives' Enterprise Value fell 3503.98% to -$59273.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$59273.0, marking a year-over-year decrease of 3503.98%. This contributed to the annual value of -$137470.0 for FY2024, which is 12619.13% down from last year.
- Latest data reveals that Bioadaptives reported Enterprise Value of -$59273.0 as of Q3 2025, which was down 3503.98% from -$210582.0 recorded in Q2 2025.
- Bioadaptives' Enterprise Value's 5-year high stood at -$235.0 during Q2 2024, with a 5-year trough of -$210582.0 in Q2 2025.
- Moreover, its 5-year median value for Enterprise Value was -$44513.0 (2022), whereas its average is -$61192.2.
- In the last 5 years, Bioadaptives' Enterprise Value skyrocketed by 9941.46% in 2024 and then plummeted by 8950936.17% in 2025.
- Quarter analysis of 5 years shows Bioadaptives' Enterprise Value stood at -$83126.0 in 2021, then skyrocketed by 69.39% to -$25447.0 in 2022, then tumbled by 138.83% to -$60776.0 in 2023, then crashed by 126.19% to -$137470.0 in 2024, then surged by 56.88% to -$59273.0 in 2025.
- Its last three reported values are -$59273.0 in Q3 2025, -$210582.0 for Q2 2025, and -$39564.0 during Q1 2025.